GLYCO-IBD: Glycans as new immunomodulators in inflammatory bowel disease: An opportunity for new therapeutic strategies. (Q2905968): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in de: Adding German translations) |
(Changed label, description and/or aliases in nl: Adding Dutch translations) |
||
| label / nl | label / nl | ||
GLYCO-IBD.: Glycanen als nieuwe immunomodulatoren bij inflammatoire darmziekte: een kans voor nieuwe therapeutische strategieën. | |||
Revision as of 12:23, 19 December 2021
Project Q2905968 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | GLYCO-IBD: Glycans as new immunomodulators in inflammatory bowel disease: An opportunity for new therapeutic strategies. |
Project Q2905968 in Portugal |
Statements
166,566.0 Euro
0 references
195,960.0 Euro
0 references
85.0 percent
0 references
1 July 2016
0 references
31 December 2019
0 references
IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO
0 references
Q2993205 (Deleted Item)
0 references
Identifiers
POCI-01-0145-FEDER-016601
0 references